PainReform Ltd. (PRFX)
NASDAQ: PRFX · Real-Time Price · USD
3.120
-0.190 (-5.74%)
At close: Jan 31, 2025, 4:00 PM
3.060
-0.060 (-1.92%)
After-hours: Jan 31, 2025, 5:05 PM EST
PainReform Market Cap
PainReform has a market cap or net worth of $1.74 million as of January 31, 2025. Its market cap has decreased by -50.31% in one year.
Market Cap
1.74M
Enterprise Value
-987.37K
1-Year Change
-50.31%
Ranking
Category
Stock Price
$3.12
Market Cap Chart
Since the IPO on September 1, 2020, PainReform's market cap has decreased from $69.97M to $1.74M, a decrease of -97.52%. That is a compound annual growth rate of -56.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 31, 2025 | 1.74M | -7.00% |
| Dec 31, 2024 | 1.87M | -56.42% |
| Dec 29, 2023 | 4.29M | -2.35% |
| Dec 30, 2022 | 4.39M | -68.52% |
| Dec 31, 2021 | 13.94M | -65.00% |
| Dec 31, 2020 | 39.83M | -43.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.32B |
| UnitedHealth Group | 499.25B |
| Novo Nordisk | 375.61B |
| Johnson & Johnson | 366.32B |
| AbbVie | 324.98B |
| Merck & Co. | 249.98B |
| Thermo Fisher Scientific | 228.64B |
| Abbott Laboratories | 221.89B |